Applied Molecular Transport (AMT) is a privately held venture-backed, clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platforms to create transformative oral biological therapies for patients with severe autoimmune, inflammatory, liver and metabolic diseases. Learn More
Privileged Access to GI Immunology and Convergent Pathways
Changing the Paradigm for Biologics
Applied Molecular Transport Debuts with First Patient Dosed in Phase 1b Clinical Trial of AMT-101 in Adults with Ulcerative Colitis | Learn More
No events scheduled at this time.